Short Communications 12
Depression 3 - Clinical (3)

[SC12-6] Efficacy of low-dose interleukin 2 as add-on in the treatment of unipolar and bipolar depression.

*Sara Poletti^1,2, Raffaella Zanardi^3,2, Alessandra Mandelli⁴, Veronica Aggio^1,2, Annamaria Finardi³, Cristina Lorenzi¹, Giovanna Borsellino⁵, Matteo Carminati^2,3, Elena Manfredi^2,3, Enrico Tomasi⁶, Sara Spadini¹, Cristina Colombo^2,3, Hemmo Drexhage⁷, Roberto Furlan^4,2, Francesco Benedetti^1,2 (1. Psychiatry and Clinical Psychobiology, Division of Neuroscience, Scientific Institute Ospedale San Raffaele, Milano, 2. Vita-Salute San Raffaele University, Milano , 3. Mood Disorder Unit, Scientific Institute Ospedale San Raffaele, Milano, 4. Clinical Neuroimmunology, Institute of Experimental Neurology, Division of Neuroscience, Scientific Institute Ospedale San Raffaele, Milano, 5. Neuroimmunology Unit, IRCCS Santa Lucia Foundation, Rome, Italy, 6. Hospital Pharmacy, Scientific Institute Ospedale San Raffaele, Milano , 7. Department of Immunology, Erasmus University Medical Center, Rotterdam)

Keywords:Interleukin 2, antidepressant, immunopsychiatry, Major depressive disorder, bipolar disorder